We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Braskem
BAK
$813M
| $9.91K | ﹤0.01% |
3,361
-78
| -2% | -$214 |
|
1602
Alpha Teknova
TKNO
$397M
| $9.88K | ﹤0.01% |
2,601
+532
| +26% | +$2.59K |
|
1603
Editas Medicine
EDIT
$436M
| $9.72K | ﹤0.01% |
4,744
+1,268
| +36% | +$3.66K |
|
|
BULL
1604
Webull Corp
BULL
$4.08B
| $9.41K | ﹤0.01% |
1,211
+204
| +20% | +$2.05K |
|
1605
DocGo
DCGO
$66.2M
| $9.12K | ﹤0.01% |
10,387
| – | – |
|
1606
C4 Therapeutics
CCCC
$480M
| $8.99K | ﹤0.01% |
4,709
+1,958
| +71% | +$4.64K |
|
1607
Sagimet Biosciences
SGMT
$584M
| $8.92K | ﹤0.01% |
+1,506
| New | +$10.8K |
|
1608
Humacyte
HUMA
$179M
| $8.74K | ﹤0.01% |
9,100
+2,977
| +49% | +$4.22K |
|
1609
Arcturus Therapeutics
ARCT
$216M
| $8.47K | ﹤0.01% |
1,381
+331
| +32% | +$3.58K |
|
1610
Coherus Oncology
CHRS
$181M
| $8.34K | ﹤0.01% |
+5,874
| New | +$8.56K |
|
1611
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $8.29K | ﹤0.01% |
201
-7
| -3% | -$289 |
|
1612
PLAYSTUDIOS Inc
MYPS
$72.1M
| $8.29K | ﹤0.01% |
12,723
| – | – |
|
1613
Zillow
ZG
$7.53B
| $8.26K | ﹤0.01% |
121
-5
| -4% | -$352 |
|
|
SEZL
1614
Sezzle
SEZL
$4.22B
| $7.87K | ﹤0.01% |
124
+21
| +20% | +$1.43K |
|
|
HAPN
1615
Happen Inc
HAPN
$2.25B
| $7.84K | ﹤0.01% |
414
+70
| +20% | +$1.24K |
|
1616
dLocal
DLO
$4.2B
| $7.78K | ﹤0.01% |
550
+93
| +20% | +$1.31K |
|
1617
Payoneer
PAYO
$2.41B
| $7.37K | ﹤0.01% |
1,312
+221
| +20% | +$1.28K |
|
1618
PagSeguro Digital
PAGS
$2.44B
| $7.35K | ﹤0.01% |
762
+128
| +20% | +$1.23K |
|
1619
Caribou Biosciences
CRBU
$169M
| $7.22K | ﹤0.01% |
+4,542
| New | +$9.53K |
|
1620
Codexis
CDXS
$172M
| $7.15K | ﹤0.01% |
4,389
+899
| +26% | +$1.83K |
|
|
ELME
1621
Elme Communities
ELME
$144M
| $6.88K | ﹤0.01% |
2,576
+645
| +33% | +$10.9K |
|
1622
Black Diamond Therapeutics
BDTX
$121M
| $6.73K | ﹤0.01% |
+2,769
| New | +$9.81K |
|
1623
Rani Therapeutics
RANI
$90.2M
| $6.4K | ﹤0.01% |
+4,740
| New | +$7.15K |
|
1624
Flywire
FLYW
$2.12B
| $6.29K | ﹤0.01% |
444
+75
| +20% | +$1.03K |
|
1625
Tenaya Therapeutics
TNYA
$171M
| $5.76K | ﹤0.01% |
+8,091
| New | +$11K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.